您当前的位置：
首页 >
文章列表页 >
Clinical Safety Monitoring of 3 035 Cases of Juvenile Feilike Mixture After Marketing in Hospital
更新时间：2025-04-18

    • Clinical Safety Monitoring of 3 035 Cases of Juvenile Feilike Mixture After Marketing in Hospital

      增强出版
    • “In the real world, clinical safety studies of pulmonary cough syrup (FLK) have shown that 3.03% of minors experience adverse reactions after use, mainly mild and moderate, with a good prognosis after treatment, indicating that FLK has good clinical safety.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 10, Pages: 194-200(2025)

    • DOI：10.13422/j.cnki.syfjx.20251196    

      CLC： R259;R256.11;R256.1

    • Received：19 November 2024，

      Accepted：2025-02-27，

      Published Online：07 March 2025，

      Published：20 May 2025

    移动端阅览

  • ZHU Jian,WANG Zhong,LIU Jing,et al.Clinical Safety Monitoring of 3 035 Cases of Juvenile Feilike Mixture After Marketing in Hospital[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(10):194-200. DOI： 10.13422/j.cnki.syfjx.20251196.

  •  
  •  

0

Views

3

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Evaluation of Safety of Compound Kushen Injection and Efficacy in Treatment of Inflammatory Bowel Disease Based on Zebrafish Model
Curative Effect of Tripterygium wilfordii Polyglycoside Tablets in Treatment of Rheumatoid Arthritis in Real World Based on Propensity Score Matching
Pharmacokinetic and Metabolomic Analysis of Randomized， Double-blind， Placebo-controlled，Continuous Administration of Fuqi Gubengao in Healthy Chinese Subjects
Comprehensive Evaluation of Clinical Evidence and Value of Feilike Mixture in Treatment of Acute Bronchitis with Phlegm-heat Invading Lung

Related Author

CHEN Xiaolu
LI Jiaqi
CHEN Linzhen
CHEN Qi
MA Zhiqiang
ZHAO Chongjun
MA Xieli
JIANG Quan

Related Institution

Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medical/Traditional Chinese Medicine（TCM） Processing Technology Inheritance Base of National Administration of TCM， School of Chinese Materia Medica， Beijing University of Chinese Medicine
Guang'anmen Hospital， China Academy of Chinese Medical Sciences
Yunnan Province Company Key Laboratory for Traditional Chinese Medicine（TCM） and Ethnic Drug of New Drug Creation，Yunnan Institute of Materia Medica
Key Laboratory for Clinical Research and Evaluation of TCM of National Medical Products Administration，National Clinical Research Center for Chinese Medicine Cardiology， Xiyuan Hospital of China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Henan University of Chinese Medicine
0